Skip to main content
Equibles
SNWV logo

SNWV · SANUWAVE Health, Inc.

Track SNWV — free

Use SNWV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.45 -0.15 (-3.26%) At close · Sep 2
Rebalance outlook locked
Market Cap
$40.09M
Shares
8.60M

SNWV metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.45
Market cap
$40.09M

Price action

19 metrics
Price change (1W)
-1.5%
Price change (30D)
-27.1%
Price change (3M)
-69.5%
Price change (6M)
-80.5%
Price change (YTD)
-84.6%
Price change (1Y)
-89.0%
Trailing year
Price change (5Y)
—
52-week high
$40.82
52-week low
$4.60
Change from 52-week high
-88.7%
Change from 52-week low
+0.0%
Annualized volatility
90.7%
Beta
1.1
RSI (14D)
30.9
Price vs SMA 50
-33.9%
Price vs SMA 200
-75.9%
Avg volume (3M)
197,120
Relative volume
0.1
Average dollar volume
$1.59M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
8.60M

Valuation

12 metrics
P / E (TTM)
5.0
Trailing earnings · reciprocal yield 20.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 109.8%
P / book
14.4
reciprocal yield 7.0%
FCF yield
10.6%
TTM · current market cap
Buyback yield
—
P / FCF
9.4
reciprocal yield 10.6%
P / operating cash flow
7.7
reciprocal yield 13.0%
Earnings yield
38.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.7%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 27.7%
EV / EBIT historical average (3Y)
39.1×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
39.1×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
30.2×
reciprocal yield 3.3%
EV / EBITDA historical average (5Y)
30.2×
reciprocal yield 3.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
76.3%
Operating margin
3.4%
Trailing 12 months
Net margin
34.7%
Gross profit (TTM)
$33.60M
Operating profit (TTM)
$1.50M
Net income (TTM)
$15.26M
Trailing 12 months
Diluted EPS (TTM)
$0.92
FCF margin
9.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.05

Growth

11 metrics
Revenue growth YoY
-3.1%
Year over year
Net income growth YoY
-223.8%
Revenue (TTM)
$44.02M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-6.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+38.1%
Revenue CAGR (5Y)
+61.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
547.5%
Return on assets
41.7%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
$2.64M
Free cash flow (TTM)
$4.24M
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.38M
Total assets
$36.60M
Total debt
$20.51M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.22M
Capital expenditures (TTM)
$978,000
R&D (TTM)
$2.24M
SG&A (TTM)
—
Stock compensation (TTM)
$5.89M
R&D / revenue
5.1%
Stock compensation / revenue
13.4%

Ownership (13F)

3 metrics
13F filers
50
13F filer change QoQ
-13
Institutional ownership
37.3%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
35 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1417663 CUSIP 80303D305 13F (30d) 45 filings 44 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)